Amara Raja Q1FY27: PAT +16% YoY as margins compress despite 24% revenue growth

Amara Raja Energy & Mobility's consolidated (primary basis) revenue from operations rose 23.9% YoY to ₹4,214.5 Cr in Q1 FY27 (quarter ended June 30, 2026), while consolidated PAT grew 15.9% YoY to ₹190.9 Cr from ₹164.8 Cr a year ago — profit growth trailing revenue growth, the first marker of margin pressure. The print falls short of Street PAT expectations: a pre-result preview (Univest) had pegged Q1 FY27 PAT at ₹218-277 Cr against a revenue estimate of ₹3,671-4,224 Cr — revenue landed near the top of that range but PAT missed the low end by roughly ₹27 Cr. Standalone PAT grew just 4.5% YoY (₹202.8 Cr vs ₹194.0 Cr) on 20.6% revenue growth, a materially slower profit trajectory than the consolidated number — the gap traces to subsidiary contribution, chiefly a narrower New Energy segment loss and higher other income at the group level. Both bases show margin compression. Consolidated operating margin (PBT after exceptional items plus finance cost and depreciation, less other income, over revenue from operations) came in at 9.6% versus 10.7% a year ago; net margin on total income slipped to 4.5% from 4.8%. Standalone operating margin fell to 10.1% from 11.5%. This sits well below management's own target of 13-14% EBITDA margin for the lead-acid business via efficiency gains and price increases — cost pressure in lead-acid clearly has not yet been offset by the pricing actions management flagged on the last call. Segment-wise, lead-acid batteries revenue grew a strong 22.1% YoY to ₹4,005.2 Cr — ahead of the guided mid-to-high single-digit growth — but segment result margin was a comparatively thin 6.7% (₹269.6 Cr on ₹4,005.2 Cr), pointing to the same cost/pricing squeeze. New Energy revenue was ₹209.3 Cr with the segment loss narrowing to ₹22.1 Cr from ₹35.2 Cr YoY — moving toward breakeven but still a drag. On capex, the company infused a further ₹150 Cr into wholly-owned subsidiary Amara Raja Advanced Cell Technologies (ARACT) this quarter, taking cumulative investment there to ₹1,650 Cr — an early, sizeable step against the ₹1,500-1,700 Cr FY27 capex guidance skewed toward New Energy. Two other developments this quarter tie to the print: the Andhra Pradesh Pollution Control Board revoked its 2021 closure orders on the Karakambadi and Nunegundlapalli plants on July 18, 2026, and the company withdrew the related writ petitions on August 6, 2026 — removing a long-standing regulatory overhang without any operational disruption visible in the numbers. A ₹13.3 lakh GST penalty paid in July is immaterial to the print. No management press release or call transcript was available to cross-check management's own framing of the quarter against these figures. Sequentially, headline PAT fell 39.3% QoQ (₹190.9 Cr vs ₹314.3 Cr), but that comparison is distorted: Q4 FY26 included a ₹181.15 Cr pre-tax exceptional gain (both standalone and consolidated) absent this quarter; normalizing Q4 FY26 PAT for that gain (~₹179 Cr) implies underlying sequential PAT growth of roughly 7%, not a decline. Going into Q2 FY27, the key markers are whether lead-acid pricing actions narrow the gap to the 13-14% EBITDA margin target, whether the New Energy segment continues narrowing its loss toward the guided 6-7% BESS margin, and the pace of capex deployment against the ₹1,500-1,700 Cr FY27 guidance.